Targeting Oxygen-Sensing Prolyl Hydroxylase for Metformin-Associated Lactic Acidosis Treatment
Tomoko Oyaizu-Toramaru(Keio University), Yoji Andrew Minamishima(Cincinnati Children's Hospital Medical Center), Shizuka Minamishima(Cincinnati Children's Hospital Medical Center), Takako Hishiki(Keio University), Hiroshi Morisaki(Keio University), Noriyo Hayakawa(Keio University), Akiko Kubo(Keio University), Takashi Nakamura(Keio University), Kyoji Yamaguchi(Daiichi-Sankyo (Japan)), Tomohiro Suhara(University of Hawaiʻi at Mānoa), Makoto Suematsu(Central Institute for Experimental Animals)
Cited by 18
Related Papers
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
Tumor Necrosis Factor α Stimulates Osteoclast Differentiation by a Mechanism Independent of the Odf/Rankl–Rank Interaction
|The Journal of Experimental Medicine|2000|1.3k
Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis<i>in Vitro</i><sup>1</sup>
|Endocrinology|1998|1.2k
Distinct Metabolic Flow Enables Large-Scale Purification of Mouse and Human Pluripotent Stem Cell-Derived Cardiomyocytes
|Cell stem cell|2012|1.1k
RANK Is the Essential Signaling Receptor for Osteoclast Differentiation Factor in Osteoclastogenesis
|Biochemical and Biophysical Research Communications|1998|746